A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT) (clinicaltrials.gov) - Aug 1, 2025 - P1 | N=36 | Active, not recruiting | Sponsor: Sichuan Clover Biopharmaceuticals, Inc. | Recruiting ➔ Active, not recruiting | N=76 ➔ 36 | Trial completion date: Jun 2025 ➔ Dec 2025
Enrollment change • Enrollment closed • Trial completion date • Breast Cancer • Hematological Disorders • Thrombocytopenia
|